Document ID: chunk:federal_register_of_legislation:F2023L00223:clause:1_141
Version: federal_register_of_legislation:F2023L00223
Segment Type: clause
Provision Reference: sch 1 cl 141
Character Range: 93273–94218

141     For the purposes of Table 4.1: Skin disorders:
      a)      'intermittent treatment' means a course of treatment leading to a break, treatment alternately ceasing and beginning again;
      b)      'constant treatment' means treatment that continues on a regular basis without interruption; and
      c)       'complex treatment' means treatment that requires regular and close supervision, usually by a dermatologist. Such supervision could involve regular blood tests and relevant regular physical examinations, such as blood pressure measurement. Complex treatments would be expected to have potential adverse side effects. Categories of drugs forming a part of, or the whole of, complex treatment would include high doses of systemic corticosteroids, or immunosuppressive medications such as azathioprine, methotrexate and cyclosporin. Phototherapy, photochemotherapy, or photophoresis, would also be considered complex treatments.